Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.45 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | CASP7 | P55210 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23957308 | 0.93 | KDM4E (0.43) | KDM4EUSP2HPGDTSHRMAPT | |
| SCHEMBL23957261 | 0.93 | KDM4E (0.45) | KDM4EUSP2HPGDTSHRMAPT | |
| SCHEMBL9392831 | 0.81 | KDM4E (0.49) | KDM4EUSP2HPGDTSHRMAPT | |
| SCHEMBL17711173 | 0.77 | KIF11 (0.44) | KDM4ETSHRALDH1A1CYP11B2GRIA4 | |
| SCHEMBL23045910 | 0.76 | IDO1 (0.42) | KDM4EUSP2HPGDTSHRMAPT | |
| SCHEMBL21905346 | 0.76 | PTGS2 (0.38) | ALDH1A1MAPK1LMNAPTGS2PTGS1 | |
| SCHEMBL23629590 | 0.75 | KIF11 (0.52) | KDM4EMAPTALDH1A1NPSR1GRIA4 | |
| SCHEMBL23629573 | 0.75 | PTPN1 (0.50) | KDM4EHPGDMAPTMEN1KMT2A | |
| SCHEMBL17711160 | 0.75 | HSD17B10 (0.47) | KDM4EHPGDMAPTHSD17B10MEN1 | |
| SCHEMBL3950371 | 0.74 | ALDH1A1 (0.42) | KDM4EHPGDMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12122768-B2 | Benzonitrile derivative, light-emitting material, and light-emitting element using same | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2024-10-22 | — | — | US | disclosed |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2021-10-28 | — | — | US | disclosed |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2021-10-28 | — | — | US | disclosed |
| EP-3848352-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | Kyushu University, National University Corporation (JP) | 2021-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12122768-B2 | Benzonitrile derivative, light-emitting material, and light-emitting element using same | INTS9, GTF2I, BRI3BP | KDM4E 1054/4885USP2 3226/4885HPGD 3563/4885 |
| US-20210332032-A1 | BENZONITRILE DERIVATIVE, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT USING SAME | INTS9, GTF2I, BRI3BP | KDM4E 1054/4885USP2 3226/4885HPGD 3563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.